시장보고서

상품코드

1629315

세계의 색전요법 시장 : 제품별, 용도별, 최종 용도별, 시술별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

Embolotherapy Market, By Product, By Application, By End Use, By Procedure, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

발행일: 2024년 12월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 311 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

색전요법 시장 규모는 2024년 41억 1,520만 달러로 2025년부터 2032년까지 CAGR 8.60%로 확대될 전망입니다.

색전요법 시장 역학

대상 환자 확대에 따른 대상 시술 증가

색전요법 기기 시장은 대상 환자층의 확대에 따른 대상 시술의 증가로 지난 10년간 꾸준히 성장해 왔으며, CVD는 주요 대상 질환으로 그 중요성과 높은 발병률로 인해 성공적인 효율적인 치료법 연구가 집중되고 있습니다. 전 세계적으로 2017년 기준 2억 명 이상이 말초혈관질환을 앓고 있습니다. 같은 자료에 따르면, 이러한 질환의 유병률은 연령에 따라 증가하며, 80세 이상 연령층에서는 20% 이상의 유병률을 보입니다고 합니다. 또한, 간세포암과 간암의 유병률 증가는 색전요법 치료와 관련된 높은 성공률과 낮은 수술 후 합병증 발생률과 함께 가까운 장래에 색전요법 장치의 필요성을 증가시킬 것으로 보입니다. 간암은 여성에서 9번째, 남성에서 5번째로 많이 발생하는 암으로, 2018년 전 세계적으로 84만 명 이상이 새로 간암 진단을 받았습니다. 또한 영국에서는 지난 10년간 신장암 발병률이 42% 증가했습니다. 남성의 발병률은 38%, 여성의 증가율은 44%이었습니다.

색전요법 시장 : 주요 고려사항

리서치 애널리스트의 분석에 따르면, 세계 시장은 예측 기간(2025-2032년) 동안 연평균 약 8.60%의 CAGR로 매년 성장할 것으로 예상됩니다.

제품별로는 색전제가 2024년 가장 큰 시장 점유율을 보일 것으로 예측됐습니다.

최종 용도별로는 2024년 병원과 클리닉이 주요 부문으로 꼽혔습니다.

시술별로는 경카테터 동맥색전요법이 2024년 주요 부문으로 부상했습니다.

지역별로는 북미가 2024년 수익을 창출한 주요 시장입니다.

색전요법 시장 : 세분화 분석

세계 색전요법 시장은 제품, 용도, 최종 용도, 시술, 지역별로 세분화됩니다.

제품별로는 색전요법 코일(압입형 코일, 장착형 코일), 장착형 풍선, 색전제(마이크로스피어, 액체 색전제), 색전 플러그 시스템, 지지 장치(마이크로카테터, 가이드와이어)로 분류되며, 2024년 색전요법 시장은 색전제가 지배적이었습니다. 지배적일 것입니다. 중재적 방사선 치료에서 색전제의 사용량이 증가함에 따라 이 분야가 시장을 지배하고 있는 것으로 분석됩니다. 또한, 이 카테고리는 약물 용출성 마이크로스피어, 무딘 색전증에 대한 보정된 마이크로스피어, 원발성 또는 이차성 간 질환에 대한 방사성 이트륨-90 마이크로스피어와 같은 약물의 개발로 인해 예측 기간 동안 가장 빠른 속도로 성장할 것으로 예상됩니다. 마이크로스피어는 간세포암 치료에 자주 사용되기 때문에 그 사용의 증가는 수요 증가에 직접적으로 기여하고 있습니다. 미국 암 협회는 매년 전 세계적으로 약 85만 건의 간암 진단이 이루어지고 있다고 보고했습니다. 또한, 이 카테고리를 촉진하는 또 다른 중요한 요소는 다용도 및 생분해성 마이크로스피어를 만드는 지속적인 연구입니다. 화학요법 약물과 치료용 방사성 핵종을 결합하여 이러한 마이크로스피어는 간세포암의 효율적인 치료를 제공할 수 있습니다.

최종 용도에 따라 시장은 병원 및 클리닉, 외래 수술 센터(ASC), 기타로 구분되며, 2024년에는 병원 및 클리닉 부문이 압도적인 시장 점유율을 차지했습니다. 색전제 및 색전요법 장비의 주요 최종 소비자는 중환자실, 소규모 진료소, 대형 병원입니다. 이러한 장소에서는 혈관, 신경, 비뇨기과적 개입과 같은 최소침습적 수술의 사용이 증가함에 따라 색전요법 시술의 수가 증가하고 있습니다. 색전요법은 중재적 영상의학과와 같이 종합적인 환자 치료를 위한 인프라가 잘 구축되어 있는 시설이 선호됩니다. 병원은 외래 수술 센터보다 환자 수가 많기 때문에 색전요법 장비와 색전제에 대한 수요가 높습니다. 이 카테고리의 확대는 대규모 의료 서비스 제공자의 구매력 증가와 미국 및 기타 주요 유럽 시장에서의 색전요법 시술에 대한 상환 가능성에 의해 촉진되고 있습니다.

색전요법 시장 : 지역별 분석

2024년 북미가 색전요법에서 가장 큰 시장 점유율을 차지한 것은 최신 색전요법 기술을 보유한 전문의 센터, 중재적 방사선과, 최첨단 의료 시설 등 고도로 발달된 선진 의료 인프라가 있기 때문입니다. 특히 미국에서는 의료비가 세계 최고 수준입니다. 최첨단 기술의 도입이 촉진될 뿐만 아니라 의료 자원에 대한 막대한 투자로 색전요법과 같은 최신 의료 시술이 널리 이용되고 있습니다. 북미의 의료 인력은 고도의 자격과 경험을 갖추고 있으며, 전문 간호사 및 중재적 방사선사도 포함되어 있습니다. 색전요법의 효과적인 시행과 발전은 숙련된 인력의 확보에 달려있습니다. 또한, 이 지역은 기술 발전과 의학 연구의 최전선에 있습니다.

아시아태평양은 시장의 상당 부분을 차지할 것으로 예상됩니다. 아시아태평양에서는 암, 말초혈관질환, 신경질환과 같은 만성질환이 증가하고 있습니다. 이러한 상황은 색전요법의 완벽한 후보이기 때문에 색전요법 도구 및 시술에 대한 이 지역의 수요가 증가하고 있습니다. 아시아태평양에서는 정부와 민간 의료 서비스 제공자들이 첨단 의료 기술 및 의료 인프라에 대한 투자를 늘리고 있습니다. 세계경제포럼(World Economic Forum)은 2030년까지 아시아태평양에서 암으로 인한 사망자 수가 36명 증가할 것으로 예상하고 있으며, 2024년에는 자궁경부암으로 인한 사망자 수가 58명, 유방암으로 인한 진단자 수가 45명 증가할 것으로 예측하고 있습니다. 발생한다고 세계경제포럼은 예측하고 있습니다. 따라서 위의 요소들이 이 지역의 주도적 지위를 유지할 것으로 예상됩니다.

색전요법 시장 : 경쟁 상황

2024년 6월 보스턴 사이언티픽은 실리콘밸리에 본사를 둔 의료기기 회사 Silk Road Medical Inc.의 인수 계획을 발표했습니다. 실크 로드 메디컬은 경동맥 혈행 재건술이라는 최소침습적 치료를 통해 경동맥 질환 환자의 뇌졸중을 예방하는 제품을 제공합니다.

2024년 2월 프랑스의 선도적인 의료 영상 AI 전문기업인 AI는 자사의 CE 인증을 받은 CINA-iPE 솔루션을 Blackford AI 플랫폼에 통합하기 위한 전략적 제휴를 발표했습니다. 이번 제휴를 통해 의료 전문가들은 표준 CT 스캔 중 우발적인 폐색전증을 보다 정확하게 감지할 수 있는 최첨단 리소스를 확보할 수 있게 됐습니다.

2023년 9월 스웨덴 CDMO에서 분해성 전분 마이크로스피어 공급업체인 마그레 그룹과 서텍스 메디컬이 독점적인 세계 판매 계약을 체결했다고 발표했습니다. 이번 계약에 따라 서텍스 메디칼은 마그레 그룹의 엠보셉트 S DSM 50μm 화학색전요법 제품을 신규 및 기존 시장에서 독점적으로 판매하게 됩니다.

개요
- 부문별 점유율 분석 : 용도별
- 종양학
  - 폐암
  - 신장암
  - 간암
  - 유방암
  - 기타 암
- 말초혈관 질환
- 비뇨기과·신장과
  - 자궁근종
  - 전립선 비대증
  - 기타 비뇨기과·신장과용 용도
- 신경학
  - 뇌동정맥기형
  - 뇌동맥류
- 소화관 장애

제9장 색전요법 시장 : 최종 용도별

개요
- 부문별 점유율 분석 : 최종 용도별
- 병원과 진료소
- 외래 수술 센터(ASC)
- 기타

제10장 색전요법 시장 : 시술별

개요
- 부문별 점유율 분석 : 시술별
- 경카테터 동맥 색전요법
- 경동맥 화학 색전요법
- 경카테터 동맥 방사선 색전요법/선택적 내부 방사선 치료

제11장 색전요법 시장 : 지역별

소개
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 프랑스
- 이탈리아
- 스페인
- 영국
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 한국
- 일본
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제12장 주요 벤더 분석 : 색전요법 업계

경쟁 대시보드
기업 개요
- Terumo Corporation
- Merit Medical Systems, Inc.
- Simbionix USA Corporation
- Cook
- Boston Scientific Corporation
- Penumbra, Inc.
- Meril Life Sciences Pvt. Ltd.
- Medtronic
- BTG International Limited
- ABK Biomedical
- Abbott
- AngioDynamics
- IMBIOTECHNOLOGIES LTD.
- Debakey Medlife Private Limited
- Heraeus Holding
- Guerbet
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- BD
- Others

제13장 AnalystView의 전방위적 분석

ksm 25.02.18

REPORT HIGHLIGHT

Embolotherapy Market size was valued at US$ 4,115.2 Million in 2024, expanding at a CAGR of 8.60% from 2025 to 2032.

Embolotherapy is the practice of treating or halting uncontrollable bleeding by blocking arteries with a device (such as a balloon catheter). By using this method, bleeding is managed, and tumours are decreased. By limiting abnormal blood vessels, this endovascular technique aims to halt bleeding. Postpartum conditions, pelvic tract bleeding, and cervical uprooted pregnancy are the main conditions treated with embolotherapy. Lesions to the liver, spleen, and kidneys are among the vascular, non-operative, and iatrogenic solid organ damage that this treatment has demonstrated potential to treat. Embolotherapy is used to remove duodenal varices, revascularize tissues and organs before surgery, and treat enlarged uterine fibroids. Selecting an embolization agent with the required degree of vascular blockage persistence is therefore required. The need for embolotherapy will expand due to the growing prevalence of liver and hepatic cancers, as well as the top manufacturers' heightened focus on technological advancements. Additionally, increased infrastructure construction expenses and better research & development skills to promote healthcare technology will drive growth in the embolotherapy market. Growing patient demand for minimally invasive procedures and increased personal disposable income are other factors driving market expansion.

Embolotherapy Market- Market Dynamics

Increase in target procedures due to the expanding target patient pool

The market for embolotherapy devices has grown steadily over the past ten years as a result of an increase in target procedures due to the expanding target patient pool. CVD is a major target illness, and because of its significance and high incidence, research on successful and efficient treatments has focused on it. Globally, more than 200 million people had peripheral vascular disorders as of 2017. The same source claims that the prevalence of these illnesses increases with age, with a prevalence rate of more than 20% seen in the over-80 age range. Moreover, The increasing prevalence of hepatocellular and liver cancers, along with the high success rate and low rate of post-operative complications linked to embolotherapy treatments, will increase the need for embolotherapy devices in the near future. The ninth most prevalent cancer in women and the fifth most common in men is liver cancer. More than 840,000 new cases were diagnosed worldwide in 2018. In addition, the UK had a 42% increase in kidney cancer incidence rates during the previous ten years. There was a 38% incidence rate in males and a 44% increase rate in females.

Embolotherapy Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.60% over the forecast period (2025-2032)

Based on product segmentation, the embolic agents were predicted to show maximum market share in the year 2024

Based on end use segmentation, hospitals and clinics were the leading segment in 2024

Based on procedure segmentation, Transcatheter Arterial Embolization was the leading segment in 2024

On the basis of region, North America was the leading revenue generator in 2024

Embolotherapy Market- Segmentation Analysis:

The Global Embolotherapy Market is segmented on the basis of Product, Application, End Use, Procedure, and Region.

On the basis of product, the market is segregated into Embolization Coil (Pushable Coils, Detachable Coils), Detachable Balloons, Embolic Agents (Microspheres, Liquid Embolic Agents), Embolic Plug Systems, and Support Devices (Microcatheters, Guidewires). The market for embolotherapy is dominated by embolic agents in 2024. For the most part, this segment dominates the market because of the growing usage of embolic agents in several interventional radiological treatments. Additionally, the category is anticipated to grow at the fastest rate during the forecast period due to the developments in such agents, such as drug-eluting microspheres, calibrated microspheres for bland embolization, and radioactive yttrium-90 microspheres for primary or secondary liver diseases. Since microspheres are frequently employed to treat HCC, their increasing use directly contributes to the demand for them. The American Cancer Society reports that about 850,000 liver cancer diagnoses are made worldwide each year. Moreover, another important factor propelling this category is the continuous study of creating multipurpose and biodegradable microspheres. By combining chemotherapeutic drugs with therapeutic radionuclides, these microspheres can provide an efficient treatment for HCC.

Based on end use, the market is divided into Hospitals and Clinics, Ambulatory Surgical Centers (ASCs), and Others. In 2024, the hospitals and clinics category held a dominant market share. The primary end consumers of embolic agents and embolotherapy equipment are critical care units, minor clinics, and large hospitals. At these locations, the number of embolotherapy procedures is being driven by the growing use of minimally invasive surgical procedures, such as vascular, neurological, and urological interventions. For embolization operations, facilities with established infrastructure that facilitates all-encompassing patient care-such as interventional radiology departments-are favoured. There is a greater need for embolotherapy equipment and embolic agents in hospitals because they have more patients than ambulatory surgery centres. The expansion of this category is also fueled by the larger healthcare providers' growing purchasing power and the availability of reimbursement for embolotherapy procedures in the United States and other significant European markets.

Embolotherapy Market- Geographical Insights

In 2024, North America held the largest market share for embolotherapy because of its highly developed and advanced healthcare infrastructure, which includes specialist centres with the newest embolotherapy technology, interventional radiology departments, and state-of-the-art medical facilities. Particularly in the United States, healthcare spending is among the highest in the world. In addition to facilitating the adoption of cutting-edge technologies, the substantial investment in healthcare resources makes modern medical procedures, such as embolotherapy, widely accessible. The healthcare workforce in North America is highly qualified and experienced and includes specialized nursing personnel and interventional radiologists. The effective implementation and growth of embolotherapy treatments depend on the availability of skilled personnel. The area is also at the forefront of technical advancement and medical research.

The Asia-Pacific region is anticipated to account for a sizeable portion of the market. In Asia-Pacific nations, chronic illnesses like cancer, peripheral vascular disease, and neurological disorders are on the rise. The region's need for embolization tools and procedures is rising as a result of these situations being perfect candidates for embolization operations. In Asia Pacific, governments and private healthcare providers are investing more in state-of-the-art medical technology and healthcare infrastructure. 50% of all new cancer cases worldwide occur in Asia Pacific, and by 2030, the number of cancer-related fatalities in Asia is predicted to rise by 36%. In 2024, the World Economic Forum anticipated that 58% of cervical cancer fatalities and 45% of all breast cancer diagnoses globally occur in Asia. Therefore, it is anticipated that the elements above will maintain the region's leading position.

Embolotherapy Market- Competitive Landscape:

Key players in the embolotherapy market include Terumo Corporation, Merit Medical Systems, Inc., Simbionix USA Corporation, Cook, Boston Scientific Corporation, Penumbra, Inc., Meril Life Sciences Pvt. Ltd., Medtronic, and others. The market's companies have been concentrating on innovations. Offering more effective solutions in response to changing end-user needs is a major focus. The market for embolotherapy is thought to be fairly fragmented because of the large number of players. In addition, industry participants have made partnerships a crucial tactic in their efforts to broaden both their product offerings and their geographical presence. For instance, in December 2023, the innovative AZUR HydroPack Peripheral Coil System from Terumo Medical Corporation was introduced in the US. A platinum and hydrogel coil with a flexible, universal shape, the AZUR HydroPack Coil System is made to locate and fill space inside the vessel.

Recent Development

June 2024: Boston Scientific Corporation announced plans to buy Silk Road Medical Inc., a medical device firm based in Silicon Valley. Through a minimally invasive treatment called trans carotid artery revascularization, the latter provides products to help patients with carotid artery disease avoid strokes.

February 2024: Leading French medical imaging AI specialist AI announced a strategic partnership to integrate its CE-marked CINA-iPE solution into the Blackford AI Platform. This collaboration gives medical professionals cutting-edge resources to detect incidental pulmonary embolisms during standard CT scans more accurately.

September 2023: Magle Group, a Swedish CDMO and vendor of degradable starch microspheres, and Sirtex Medical announced an exclusive global distribution deal. Sirtex Medical exclusively distributes the EmboCept S DSM 50 μm chemoembolization product from Magle Group in both new and existing markets as part of the collaboration.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL EMBOLOTHERAPY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Terumo Corporation
Merit Medical Systems, Inc.
Simbionix USA Corporation
Cook
Boston Scientific Corporation
Penumbra, Inc.
Meril Life Sciences Pvt. Ltd.
Medtronic
BTG International Limited
ABK Biomedical
Abbott
AngioDynamics
IMBIOTECHNOLOGIES LTD.
Debakey Medlife Private Limited
Heraeus Holding
Guerbet
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
BD
Others

GLOBAL EMBOLOTHERAPY MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

Embolization Coil
Pushable Coils
Detachable Coils
Detachable Balloons
Embolic Agents
Microspheres
Liquid Embolic Agents
Embolic Plug Systems
Support Devices
Microcatheters
Guidewires

GLOBAL EMBOLOTHERAPY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Oncology
Lung Cancer
Kidney Cancer
Liver Cancer
Breast Cancer
Other Cancers
Peripheral Vascular Diseases
Urology and Nephrology
Uterine Fibroids
Benign Prostatic Hyperplasia
Other Urology and Nephrology Applications
Neurology
Cerebral Arteriovenous Malformations
Brain Aneurysm
GIT Disorders

GLOBAL EMBOLOTHERAPY MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

Hospitals and Clinics
Ambulatory Surgical Centers (ASCs)
Others

GLOBAL EMBOLOTHERAPY MARKET, BY PROCEDURE- MARKET ANALYSIS, 2019 - 2032

Transcatheter Arterial Embolization
Transarterial Chemoembolization
Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy

GLOBAL EMBOLOTHERAPY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Embolotherapy Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Embolotherapy Market Snippet by Product
- 2.1.2. Embolotherapy Market Snippet by Application
- 2.1.3. Embolotherapy Market Snippet by End Use
- 2.1.4. Embolotherapy Market Snippet by Procedure
- 2.1.5. Embolotherapy Market Snippet by Country
- 2.1.6. Embolotherapy Market Snippet by Region
2.2. Competitive Insights

3. Embolotherapy Key Market Trends

3.1. Embolotherapy Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Embolotherapy Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Embolotherapy Market Opportunities
3.4. Embolotherapy Market Future Trends

4. Embolotherapy Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Embolotherapy Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Embolotherapy Market Landscape

6.1. Embolotherapy Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Embolotherapy Market - By Product

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
- 7.1.2. Embolization Coil
  - 7.1.2.1. Pushable Coils
  - 7.1.2.2. Detachable Coils
- 7.1.3. Detachable Balloons
- 7.1.4. Embolic Agents
  - 7.1.4.1. Microspheres
  - 7.1.4.2. Liquid Embolic Agents
- 7.1.5. Embolic Plug Systems
- 7.1.6. Support Devices
  - 7.1.6.1. Microcatheters
  - 7.1.6.2. Guidewires

8. Embolotherapy Market - By Application

8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 8.1.2. Oncology
  - 8.1.2.1. Lung Cancer
  - 8.1.2.2. Kidney Cancer
  - 8.1.2.3. Liver Cancer
  - 8.1.2.4. Breast Cancer
  - 8.1.2.5. Other Cancers
- 8.1.3. Peripheral Vascular Diseases
- 8.1.4. Urology and Nephrology
  - 8.1.4.1. Uterine Fibroids
  - 8.1.4.2. Benign Prostatic Hyperplasia
  - 8.1.4.3. Other Urology and Nephrology Applications
- 8.1.5. Neurology
  - 8.1.5.1. Cerebral Arteriovenous Malformations
  - 8.1.5.2. Brain Aneurysm
- 8.1.6. GIT Disorders

9. Embolotherapy Market - By End Use

9.1. Overview
- 9.1.1. Segment Share Analysis, By End Use, 2024 & 2032 (%)
- 9.1.2. Hospitals and Clinics
- 9.1.3. Ambulatory Surgical Centers (ASCs)
- 9.1.4. Others

10. Embolotherapy Market - By Procedure

10.1. Overview
- 10.1.1. Segment Share Analysis, By Procedure, 2024 & 2032 (%)
- 10.1.2. Transcatheter Arterial Embolization
- 10.1.3. Transarterial Chemoembolization
- 10.1.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy

11. Embolotherapy Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Embolotherapy Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Embolotherapy Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.3.9. France
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.9.5. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.3.9.6. France Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.3.10. Italy
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.10.5. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.3.10.6. Italy Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.3.11. Spain
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.11.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.11.5. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.3.11.6. France Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.3.12. United Kingdom
  - 11.3.12.1. Overview
  - 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.12.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.12.5. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.3.12.6. United Kingdom Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.3.13. Russia
  - 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.13.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.13.4. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.3.13.5. Russia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.3.14. Netherlands
  - 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.14.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.14.4. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.3.14.5. Netherlands Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.3.15. Sweden
  - 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.15.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.15.4. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.3.15.5. Sweden Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.3.16. Poland
  - 11.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.16.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.16.4. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.3.16.5. Poland Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.3.17. Rest of Europe
  - 11.3.17.1. Overview
  - 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.17.5. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.3.17.6. Rest of the Europe Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Embolotherapy Key Manufacturers in Asia Pacific
- 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.6. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.7. Asia Pacific Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.4.8. India
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.8.5. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.4.8.6. India Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.4.9. China
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.9.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.9.5. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.4.9.6. China Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.4.10. South Korea
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.10.5. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.4.10.6. South Korea Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.4.11. Japan
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.11.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.11.5. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.4.11.6. Japan Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.4.13. Thailand
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.13.5. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.4.13.6. Thailand Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.4.14. Indonesia
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.14.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.14.5. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.4.14.6. Indonesia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.16.5. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.4.16.6. Rest of APAC Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
11.5. Latin America
- 11.5.1. Overview
- 11.5.2. Embolotherapy Key Manufacturers in Latin America
- 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.6. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.5.7. Latin America Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa
- 11.6.1. Overview
- 11.6.2. Embolotherapy Key Manufacturers in Middle East and Africa
- 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.6. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.6.7. Middle East and Africa Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.14.5. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  - 11.6.14.6. Rest of MEA Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Embolotherapy Industry

12.1. Competitive Dashboard
12.2. Company Profiles
- 12.2.1. Terumo Corporation
- 12.2.2. Merit Medical Systems, Inc.
- 12.2.3. Simbionix USA Corporation
- 12.2.4. Cook
- 12.2.5. Boston Scientific Corporation
- 12.2.6. Penumbra, Inc.
- 12.2.7. Meril Life Sciences Pvt. Ltd.
- 12.2.8. Medtronic
- 12.2.9. BTG International Limited
- 12.2.10. ABK Biomedical
- 12.2.11. Abbott
- 12.2.12. AngioDynamics
- 12.2.13. IMBIOTECHNOLOGIES LTD.
- 12.2.14. Debakey Medlife Private Limited
- 12.2.15. Heraeus Holding
- 12.2.16. Guerbet
- 12.2.17. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- 12.2.18. BD
- 12.2.19. Others

13. 360 Degree Analyst View

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us